Strata (SRTA) Co‑CEO Melissa Tomkiel Receives Award

What Happened
Melissa M. Tomkiel, Co‑CEO, General Counsel and Director of Strata Critical Medical (SRTA), had performance‑based restricted stock units (PSUs) certify and vest. On 2026-07-30 she was issued two PSU awards totaling 415,882 shares (208,929 and 206,953) at $0.00 acquisition price. On 2026-07-31 the issuer withheld 212,309 of those shares to satisfy tax withholding obligations, reported at $5.09 per share for a withholding value of $1,080,653. Net shares delivered from these awards equal 415,882 − 212,309 = 203,573 shares.

Key Details

• Transaction dates: Awards vested/acquired 2026-07-30; tax withholding disposition 2026-07-31. Form filed 2026-08-03.
• Prices/values: Awards acquired at $0.00. Withheld 212,309 shares at $5.09 = $1,080,653 (tax withholding).
• Shares owned after transaction: Not specified in the filing; net newly issued to Tomkiel from these awards = 203,573 shares.
• Footnotes: F1 = PSUs from March 8, 2024 award certified; F2 = PSUs from March 20, 2025 award certified; F3 = shares withheld to satisfy tax obligations.
• Filing timeliness: Report filed 2026-08-03 for 2026-07-30/31 transactions; the form does not indicate a late‑filing flag.

Context
These were vested performance awards (PSUs), not open‑market buys or option exercises. The reported "disposition" is a routine cashless withholding of shares to cover taxes rather than a market sale for cash. Award vesting is a compensation event and does not by itself signal insider buying or selling intent.